Raymond James Financial Services Advisors, Inc. Palatin Technologies Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$0.98 - $1.64 $15,498 - $25,936	-15,815 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$0.63 - $1.0 $1,260 - $2,000	-2,000 Reduced 11.23%	15,815 $11,000
Q2 2018 Jul 30, 2018	BUY	$0.91 - $1.45 $2,730 - $4,350	3,000 Added 20.25%	17,815 $17,000
Q4 2017 Feb 09, 2018	BUY	$0.68 - $1.0 $6 - $10	10 Added 0.07%	14,815 $13,000
Q3 2017 Oct 26, 2017	SELL	$0.39 - $0.66 $390 - $660	-1,000 Reduced 6.33%	14,805 $10,000
Q2 2017 Aug 15, 2017	BUY	N/A	15,805	15,805 $7,000

Others Institutions Holding PTN

# of Institutions

Shares Held

2.94K

Call Options Held

Put Options Held

Cordasco Financial Network

2.94K
Shares

$2,587
0.0% of portfolio

View Full List

About PALATIN TECHNOLOGIES INC

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.18M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

More about PTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account